Literature DB >> 23104213

Combining molecular markers with the TNM staging system to improve prognostication in stage II and III colon cancer: are we ready yet?

Frank A Sinicrope, Qian Shi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104213     DOI: 10.1093/jnci/djs441

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

2.  Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.

Authors:  Frank A Sinicrope; Michelle R Mahoney; Thomas C Smyrk; Stephen N Thibodeau; Robert S Warren; Monica M Bertagnolli; Garth D Nelson; Richard M Goldberg; Daniel J Sargent; Steven R Alberts
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

Review 3.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

Review 4.  What is the optimal means of staging colon cancer?

Authors:  Elizabeth A Arena; Anton J Bilchik
Journal:  Adv Surg       Date:  2013

5.  Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.

Authors:  Lulu Ma; Wenya Li; Ningquan Liu; Zhijie Ding; Jianchun Cai; Yiyao Zhang
Journal:  Updates Surg       Date:  2022-03-24

Review 6.  Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer.

Authors:  Luigi Laghi; Francesca Negri; Federica Gaiani; Tommaso Cavalleri; Fabio Grizzi; Gian Luigi De' Angelis; Alberto Malesci
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.